“A Utah-based nonprofit pharmaceutical manufacturer is gearing up to kick off production at its new Petersburg plant about two years after breaking ground.
With construction largely complete on the $140 million facility, Civica Rx expects to start making insulin there this year, Senior Vice President Allan Coukell said in an interview last week.
“We begin a long phase of validating the equipment and doing initial manufacturing runs that will be subject to FDA approval,” Coukell said. “We’re staffing up now and beginning to shift into the manufacturing phase.”
While production is expected to start this year, the 140,000-square-foot plant’s output is slated to first hit the market in 2024.”